Transgenic mammals and methods of use thereof
US10662256B2 · kind B2 · utility
0Cited by
46References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 23, 2017 |
| Grant date | May 26, 2020 |
| Priority date | — |
| Expiry date | Jan 24, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to transgenic mammals that express canine-based immunoglobulins, including transgenic rodents that express canine-based immunoglobulins for the development of canine therapeutic antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.